ArticleRSC advances2022
Application of a needle trap device packed with a MIP@MOF nano-composite for efficient sampling and determination of airborne diazinon pesticide.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A novel MOF combined with dummy molecularly imprinted polymer paper-based colorimetric sensor equipped with a smartphone detector for sensitive, portable, and on-site detection of organophosphorus pesticides.Mikrochimica acta · 2025Article
- Development of a needle trap device packed with modified PAF-6-MNPs for sampling and analysis of polycyclic aromatic compounds in air.RSC advances · 2024Article
- Progress on Electrochemical Biomimetic Nanosensors for the Detection and Monitoring of Mycotoxins and Pesticides.Toxins · 2024Review
- Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the art.Journal of pharmaceutical analysis · 2024Review
- [Recent advances in the applications of metal-organic frameworks-based molecularly imprinted materials].Se pu = Chinese journal of chromatography · 2023Article
- Investigation of organophosphorus (OPs) compounds by a needle trap device based on mesoporous organo-layered double hydroxide (organo-LDH).RSC advances · 2023Article
- Urinary bio-monitoring of aromatic amine derivatives by new needle trap device packed with the multi-component adsorbent.Scientific reports · 2023Article
- Application of MIL-53(Al)-NHACS omega · 2022Article
- Template Imprinting Versus Porogen Imprinting of Small Molecules: A Review of Molecularly Imprinted Polymers in Gas Sensing.International journal of molecular sciences · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this research, a novel, selective, and efficient porous adsorbent nano-composite comprising a molecularly imprinted polymer and a metal-organic framework (MIP@MOF) was employed for sampling, extraction and analysis of diazinon from the air by a needle trap device (NTD), for the first time. The synthesized MIP@MOF sorbent was characterized by the FT-IR, XRD, FE-SEM, TEM, and EDS techniques. Then, the effective parameters of the sampling (temperature and humidity) and desorption (time and temperature) process were optimized by response surface methodology (RSM). The optimum values of temperature and humidity of the sampling chamber were estimated to be 20 °C and 25.0%, respectively. Also, the highest response during the analyte desorption was obtained at 262 °C and 4.5 minutes. For more details, the performance of the MIP@MOF:NTD method was evaluated by determination of important parameters such as repeatability, reproducibility, the limit of detection (LOD), and the limit of quantification (LOQ), and then compared with the NIOSH 5600 standard method. The values of LOD and LOQ for the targeted analyte were determined to be 0.02 and 0.1 μg m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.